ALPS Advisors’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-44,238
| Closed | -$910K | – | 1007 |
|
|
2023
Q3 | $910K | Buy |
44,238
+308
| +0.7% | +$6.34K | 0.01% | 488 |
|
|
2023
Q2 | $2.07M | Buy |
43,930
+4,585
| +12% | +$216K | 0.02% | 301 |
|
|
2023
Q1 | $1.65M | Sell |
39,345
-985
| -2% | -$41.3K | 0.01% | 327 |
|
|
2022
Q4 | $1.54M | Buy |
40,330
+7,884
| +24% | +$301K | 0.01% | 350 |
|
|
2022
Q3 | $1.27M | Sell |
32,446
-2,592
| -7% | -$102K | 0.01% | 394 |
|
|
2022
Q2 | $1.13M | Sell |
35,038
-25,654
| -42% | -$829K | 0.01% | 456 |
|
|
2022
Q1 | $2.01M | Sell |
60,692
-7,482
| -11% | -$248K | 0.02% | 207 |
|
|
2021
Q4 | $2.9M | Sell |
68,174
-3,904
| -5% | -$166K | 0.03% | 200 |
|
|
2021
Q3 | $3.19M | Sell |
72,078
-9,076
| -11% | -$402K | 0.03% | 212 |
|
|
2021
Q2 | $4.61M | Buy |
81,154
+76,719
| +1,730% | +$4.36M | 0.04% | 180 |
|
|
2021
Q1 | $332K | Buy |
+4,435
| New | +$332K | ﹤0.01% | 708 |
|
|
2017
Q4 | – | Sell |
-36,874
| Closed | -$2.3M | – | 878 |
|
|
2017
Q3 | $2.3M | Buy |
36,874
+3,165
| +9% | +$197K | 0.02% | 179 |
|
|
2017
Q2 | $2.69M | Buy |
33,709
+1,734
| +5% | +$138K | 0.02% | 169 |
|
|
2017
Q1 | $2.27M | Sell |
31,975
-3,741
| -10% | -$266K | 0.02% | 169 |
|
|
2016
Q4 | $1.82M | Sell |
35,716
-5,198
| -13% | -$265K | 0.01% | 182 |
|
|
2016
Q3 | $1.88M | Sell |
40,914
-4,130
| -9% | -$190K | 0.02% | 188 |
|
|
2016
Q2 | $1.36M | Buy |
45,044
+9,036
| +25% | +$272K | 0.01% | 196 |
|
|
2016
Q1 | $1.15M | Sell |
36,008
-2,013
| -5% | -$64.5K | 0.01% | 181 |
|
|
2015
Q4 | $2.22M | Sell |
38,021
-6,380
| -14% | -$372K | 0.02% | 169 |
|
|
2015
Q3 | $18.8K | Buy |
44,401
+16,267
| +58% | +$6.88K | 0.02% | 174 |
|
|
2015
Q2 | $2.05M | Buy |
28,134
+15,272
| +119% | +$1.11M | 0.02% | 167 |
|
|
2015
Q1 | $646K | Buy |
+12,862
| New | +$646K | 0.01% | 206 |
|